ATHE ALTERITY THERAPEUTICS LTD: institutional ownership and insider trading
24 funds reported holding $2.01M of ALTERITY THERAPEUTICS LTD in their latest 13F filings; in Q2 2026 funds net bought $395K, with 6 new positions and 0 funds selling out; over the last 12 months insiders bought $23.8K and sold $0 on the open market.
Famous investors holding ATHE
- Ken Griffin (Citadel Advisors): $202K, 0.0% of the portfolio
Largest institutional holders of ATHE
- Twin Lakes Capital Management, LLC — $748K
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $339K
- GREENLEAF TRUST — $333K
- HB Wealth Management, LLC — $213K
- CITADEL ADVISORS LLC — $202K
- HRT FINANCIAL LP — $92.0K
- BNP PARIBAS FINANCIAL MARKETS — $55.0K
- RHUMBLINE ADVISERS — $10.8K
- ACADIAN ASSET MANAGEMENT LLC — $10.0K
- GAMMA Investing LLC — $5.21K
Recent ATHE insider trades
- Aug 31, 2026: Marks Peter Ashley bought 47,620 shares ($23.8K)
5%+ owners
- JPMORGAN CHASE & CO.: 6.3% (Schedule 13G, filed May 2, 2025)